MENU
TYRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tyra Biosciences (TYRA) Ownership - Who owns Tyra Biosciences?
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology... Show more
Profile
Industry
N/A
Address
2656 State Street
Phone
+1 619 728-4760
Employees
49
Web
https://www.tyra.bio
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
673.68M
P/E Ratio
N/A
Total Cash
296.27M
Projected Growth
N/A
Total Debt
6.02M
Revenue
N/A
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
5.56
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TYRA
Capitalization
674M
P/E Ratio
N/A
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
296M
Total Cash/Share
5.56
Total Debt
6.02M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
302M
P/B Ratio
2.27
Cash Flow
N/A
Earnings
-1.79
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
21.94
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-121.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.65
Shares Held By Institutions
588M
Shares Outstanding - Current
53.3M
Total Liabilities
19.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-7.338
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TYRA showed earnings on August 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2656 State Street
Phone
+1 619 728-4760
Employees
49
Web
https://www.tyra.bio